RPS6 through the activation of NRF2 causes resistance to antiHER2 drugs in HER2 amplified gastric cancer (GC) models
Titel:
RPS6 through the activation of NRF2 causes resistance to antiHER2 drugs in HER2 amplified gastric cancer (GC) models
Auteur:
Gambardella, V. Valiente, F.G. Tarazona, N. Roda, D. Tolosa, P. Fleitas Kanonnikoff, T. Garcia Mico, B. Huerta, M. Rosello, S. Martinez-Ciarpaglini, C. Cervantes, A. Castillo, J.